Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Insulinoma × Surgical Procedures, Operative × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 52 Breast Neoplasms 47 Rectal Neoplasms 41 Stomach Neoplasms 33 Glioblastoma 32 Esophageal Neoplasms 30 Brain Neoplasms 27 Colorectal Neoplasms 24 Squamous Cell Carcinoma of Head and Neck 23 Pancreatic Neoplasms 21 Neoplasms 21 Lung Neoplasms 21 Glioma 18 Astrocytoma 18 Neoplasm Metastasis 16 Head and Neck Neoplasms 16 Esophageal Squamous Cell Carcinoma 15 Sarcoma 14 Ovarian Neoplasms 13 Gliosarcoma 13 Central Nervous System Neoplasms 13 Melanoma 11 Adenocarcinoma Of Esophagus 11 Prostatic Neoplasms 10 Oligodendroglioma 10 Colonic Neoplasms 10 Carcinoma, Hepatocellular 10 Urinary Bladder Neoplasms 9 Oropharyngeal Neoplasms 9 Carcinoma, Ovarian Epithelial 9

Interventions

Octreotide 4 Leucovorin 3 Everolimus 3 vatalanib 2 fluorodopa F 18 2 Trastuzumab 2 Oxaliplatin 2 Fluorouracil 2 Capecitabine 2 Bortezomib 2 veliparib 1 tipifarnib 1 romidepsin 1 pazopanib 1 motesanib diphosphate 1 cixutumumab 1 batifiban 1 Thalidomide 1 Temozolomide 1 Surgical Procedures, Operative 1 Streptozocin 1 Salts 1 Panobinostat 1 Melphalan 1 Irinotecan 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 High-Energy Shock Waves 1 Gefitinib 1 Floxuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05735912 2026-01-13

ERASIN-RCT

Azienda Ospedaliera Universitaria Integrata Verona

Phase NA Active not recruiting

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡